Malaysian doctors back 2-D ultrasound

Article

Ultrasound specialists and obstetricians in Malaysia are complaining that the publicity surrounding three-dimensional ultrasound implies that two-dimensional technology is obsolete, “engendering tremendous anxiety among both patients and

Ultrasound specialists and obstetricians in Malaysia are complaining that the publicity surrounding three-dimensional ultrasound implies that two-dimensional technology is obsolete, “engendering tremendous anxiety among both patients and doctors,” according to an article in the New Straits Times.

These physicians point out that development in recent years of high-resolution 2-D probes and color Doppler ultrasound has enabled doctors to obtain images of the fetus with better clarity. Consequently, doctors are able to diagnose fetal abnormalities earlier in the pregnancy with greater confidence.

“Conventional 2-D ultrasound remains the primary method for detection of fetal abnormalities,” said Dr. Ravi Chandran, president of the Malaysian Society of Ultrasound in Medicine. “Three-D ultrasound is a developing technology and has yet to be shown to be superior to 2-D ultrasound in this respect.”

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.